Company / Current Liabilities
ALX ONCOLOGY HOLDINGS INC Current Liabilities History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$28.3M
FY2022
5-year range
$6.2M / $28.3M
FY2020-FY2022
Trend
+85.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $6M to $28M over the past 2 years.
Based on SEC 10-K filings.
$28M in FY2022.
Increased from $6M to $28M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities increased 85.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $28.3M | +85.2% |
| FY2021 | $15.3M | +146.5% |
| FY2020 | $6.2M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026